Tenon Medical Announces 1-for-35 Reverse Stock Split

What Happened

• Tenon Medical, Inc. (TNON) filed an 8-K to report a 1-for-35 reverse stock split of its common stock, effective 12:01 a.m. Eastern Time on August 10, 2026. The Company’s board approved the 1-for-35 ratio following stockholder approval (at the July 23, 2026 annual meeting) of a reverse split within the range 1-for-2 to 1-for-35.
• The Certificate of Amendment was filed with the Delaware Secretary of State and the Common Stock began trading on a reverse-split-adjusted basis on the Nasdaq Capital Market on August 10, 2026. The trading symbol remains “TNON.”

Key Details

• Reverse split ratio: 1-for-35 (every 35 shares combined into 1 share).
• Effective date/time: 12:01 a.m. ET on August 10, 2026; press release issued August 6, 2026.
• Fractional shares: no fractional shares issued; fractional entitlements were rounded up to the next whole share.
• Administrative adjustments: proportionate adjustments were made to option exercise prices and share counts, shares reserved under equity incentive plans, outstanding warrants (shares and exercise prices), and restricted stock unit conversion amounts.
• New CUSIP: 88066N402; trading symbol unchanged: TNON.

Why It Matters

• The reverse split reduces the number of outstanding shares and increases the per‑share metrics proportionately; it does not change each shareholder’s percentage ownership (after rounding adjustments) or the economic value of securities once contractual adjustments are applied.
• Investors should note the adjusted option/warrant/RSU terms and the new CUSIP when reviewing holdings or placing trades; the company communicated the change via a press release and filed the executed Certificate of Amendment with Delaware.